Celltrion Pharm Inc (068760) — Net Asset Quality Index
Celltrion Pharm Inc (068760) has a Net Asset Quality Index of 57.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩745.80 Billion minus total liabilities of ₩319.38 Billion yields net assets of ₩426.42 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 068760 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Celltrion Pharm Inc Net Asset Quality Index Over Time (2011–2024)
This chart shows how Celltrion Pharm Inc's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at 57.2%, representing net assets of ₩426.42 Billion against total assets of ₩745.80 Billion KRW. Explore Celltrion Pharm Inc cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Celltrion Pharm Inc (2011–2024)
The table below presents the year-by-year Net Asset Quality Index for Celltrion Pharm Inc from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 068760 stock market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 59.3% | ₩396.92 Billion | ₩669.46 Billion | ₩272.54 Billion | ▲ +0.6 pp |
| 2023 | 58.7% | ₩376.67 Billion | ₩641.64 Billion | ₩264.98 Billion | ▼ -0.8 pp |
| 2022 | 59.5% | ₩356.79 Billion | ₩599.72 Billion | ₩242.94 Billion | ▲ +7.4 pp |
| 2021 | 52.0% | ₩331.97 Billion | ₩637.88 Billion | ₩305.92 Billion | ▼ -2.8 pp |
| 2020 | 54.8% | ₩300.56 Billion | ₩548.07 Billion | ₩247.51 Billion | ▼ -4.6 pp |
| 2019 | 59.5% | ₩280.03 Billion | ₩470.98 Billion | ₩190.95 Billion | ▼ -0.2 pp |
| 2018 | 59.7% | ₩270.03 Billion | ₩452.44 Billion | ₩182.41 Billion | ▼ -2.8 pp |
| 2017 | 62.4% | ₩293.62 Billion | ₩470.27 Billion | ₩176.65 Billion | ▼ -5.1 pp |
| 2016 | 67.6% | ₩344.65 Billion | ₩510.02 Billion | ₩165.37 Billion | ▲ +17.0 pp |
| 2015 | 50.6% | ₩236.23 Billion | ₩466.77 Billion | ₩230.54 Billion | ▼ -1.5 pp |
| 2014 | 52.2% | ₩214.43 Billion | ₩411.16 Billion | ₩196.74 Billion | ▲ +5.5 pp |
| 2013 | 46.6% | ₩168.41 Billion | ₩361.35 Billion | ₩192.94 Billion | ▼ -0.9 pp |
| 2012 | 47.5% | ₩157.25 Billion | ₩331.04 Billion | ₩173.80 Billion | ▼ -11.9 pp |
| 2011 | 59.4% | ₩128.27 Billion | ₩216.08 Billion | ₩87.81 Billion | — |